Total Clarity Wealth Management, Inc. Novo Cure LTD Transaction History

Total Clarity Wealth Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$56.6 - $89.9 $7,924 - $12,586	140 New	140 $10,000
Q1 2022 Apr 29, 2022	SELL	$60.15 - $84.52 $1,203 - $1,690	-20 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$75.08 - $121.99 $497,405 - $808,183	-6,625 Reduced 99.7%	20 $2,000
Q3 2021 Oct 21, 2021	BUY	$116.17 - $194.55 $184,129 - $308,361	1,585 Added 31.32%	6,645 $772,000
Q2 2021 Jul 26, 2021	SELL	$130.4 - $225.58 $9,780 - $16,918	-75 Reduced 1.46%	5,060 $1.12 Million
Q1 2021 May 05, 2021	SELL	$124.11 - $190.17 $637,304 - $976,522	-5,135 Reduced 50.0%	5,135 $679,000
Q4 2020 Jan 20, 2021	SELL	$112.16 - $174.14 $16,824 - $26,120	-150 Reduced 1.44%	10,270 $1.78 Million
Q3 2020 Nov 17, 2020	BUY	$58.05 - $111.31 $14,512 - $27,827	250 Added 2.46%	10,420 $1.16 Million
Q2 2020 Jul 15, 2020	BUY	$57.2 - $74.41 $581,724 - $756,749	10,170 New	10,170 $603,000
Q1 2020 Apr 24, 2020	SELL	$57.05 - $95.75 $3,423 - $5,745	-60 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$68.3 - $93.8 $4,098 - $5,628	60 New	60 $5,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.